T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services
Division of Purchase and Property
- Deadline
- December 4, 202613 days left
- Contract value
- Value not stated in the notice
- Set-aside
- None stated
What it is
NJSTART 26DPP01283: T3165 - Naloxone, 4mg Nasal Spray, FDA-Approved, for the New Jersey Department of Human Services Department: DPP - Division of Purchase and Property. Purchase method: Contract. Pre-bid conference: Please refer to the Bid Solicitation.. Attachments: T3165 Bid Amendment 2 - Responses to eQA and Revisions to the Bid Solicitation 10.29.26.pdf; T3165 26DPP01283 Revised Bid Solicitation 10.29.2026; T3165 Bid Amendment 1 - Revised BOD 10.09.26; T3165 26DPP01283 Revised Bid Solicitation 10.09.2026; T3165 26DPP01283 Bid Solicitation 8.20.2026; T3165 26DPP01283 State-Supplied Price Sheet 8.20.26.
From the official listing, in the buyer's own words.
Who can bid
- Businesses registered to sell to this buyer
The notice names no set-aside, so it is not limited to one type of firm.
What it is worth
Value not stated in the notice
The listing states no figure and we hold no past awards to go by, so we show none rather than guess.
Notice details
- Notice type
- 01 - 01 - RFP
- Line of work
- human services
Rules on AI-written applications
No AI policy found — check the funder's guidelines
Other open notices like this
- T3076- New Jersey Early Intervention Services (NJEIS)Division of Purchase and PropertyDue Dec 9, 2026
- T2890S - Residential Re-entry Programming and Services: NJSPBDivision of Purchase and PropertyDue Dec 16, 2026
- T3151 Workforce Development Case Management SolutionDivision of Purchase and PropertyDue Feb 4, 2027
- T2679 - Employee Benefits: Pharmacy Benefits ManagementDivision of Purchase and PropertyDue Nov 25, 2026